Research Horizons
DONATE
Français
Research Horizons
Menu
About Research Horizons
Trending Topics:
HPV
clinical trial
T cell therapy
immunotherapy
DONATE
About Research Horizons
immunotherapy
Unleashing the power of the immune system
early diagnosis
New Canadian guidelines for colorectal cancer screening
genomics
Unique sets of genetic changes may improve sensitivity of cancer blood test
prevention
Could Aspirin prevent cancer?
Research Institute
Merck Canada
Research Impact Report
Prevention Network
Canadian Cancer Trials
News: T cell therapy
New targeted molecule may improve immunotherapy for brain cancer
Genetic signatures predict melanoma immunotherapy response
Gut bacteria may influence how well immunotherapy works
Lowering oxygen raises potential of cancer-killing T cells
How CAR-T cells work to fight cancer
FDA-approved: the first “living drug” against childhood leukemia
“Living drugs”: New immunotherapies train immune cells to fight cancer
Will immunotherapy transform cancer care?
Boosting the immune system to target cancer
Ready-or-not here we come: opening our eyes to the fight on cancer
Immunotherapy, a promising new field of cancer treatment
Supported by:
About Us
Who we are and what we do
Our history
Our research
Our partnerships
Our People
Board
News
Cancer and COVID-19 Resources
Ethical fundraising
Resource publications
Impact report
Financial statements
About our site & information
Our editorial policy
Medical disclaimer
Privacy policy
Linking policy
Terms and conditions
Need more information?
Contact us – we’re here to help
1-888-939-3333
1-866-786-3934
(TTY)
